These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 26321374)

  • 21. Children and adolescents with neurofibromatosis 1: a behavioral phenotype.
    Dilts CV; Carey JC; Kircher JC; Hoffman RO; Creel D; Ward K; Clark E; Leonard CO
    J Dev Behav Pediatr; 1996 Aug; 17(4):229-39. PubMed ID: 8856518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychological profiles associated with the children's oral language disorders].
    Conde-Guzón PA; Conde-Guzón MJ; Bartolomé-Albistegui MT; Quirós-Expósito P
    Rev Neurol; 2009 Jan 1-15; 48(1):32-8. PubMed ID: 19145564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1.
    Champion JA; Rose KJ; Payne JM; Burns J; North KN
    Dev Med Child Neurol; 2014 May; 56(5):468-74. PubMed ID: 24387687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.
    van der Vaart T; van Woerden GM; Elgersma Y; de Zeeuw CI; Schonewille M
    Genes Brain Behav; 2011 Jun; 10(4):404-9. PubMed ID: 21352477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Learning disorders in neurofibromatosis type 1].
    Garcia-Penas JJ
    Rev Neurol; 2017 Feb; 64(s01):S59-S63. PubMed ID: 28256688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
    Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
    Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
    Lidzba K; Granström S; Lindenau J; Mautner VF
    Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficit in phonological processes: a characteristic of the neuropsychological profile of children with NF1.
    Chaix Y; Lauwers-Cancès V; Faure-Marie N; Gentil C; Lelong S; Schweitzer E; Rodriguez D; Iannuzzi S; Kemlin I; Dorison N; Rivier F; Carniero M; Preclaire E; Barbarot S; Lion-François L; Castelnau P
    Child Neuropsychol; 2018 May; 24(4):558-574. PubMed ID: 28393676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
    Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
    BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical connectivity in the cortico-striatal network in NF1 children and its relationship with procedural perceptual-motor learning and motor skills.
    Baudou E; Nemmi F; Peran P; Cignetti F; Blais M; Maziero S; Tallet J; Chaix Y
    J Neurodev Disord; 2022 Mar; 14(1):15. PubMed ID: 35232382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level.
    Hachon C; Iannuzzi S; Chaix Y
    Brain Dev; 2011 Jan; 33(1):52-61. PubMed ID: 20106617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cognitive dysfunction and emotional disturbances in children with neurofibromatosis type one (Recklinghausen's disease). Review of the literature].
    Trzcińska M; Borkowska A
    Psychiatr Pol; 2005; 39(2):371-81. PubMed ID: 15881631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social functioning and facial expression recognition in children with neurofibromatosis type 1.
    Allen T; Willard VW; Anderson LM; Hardy KK; Bonner MJ
    J Intellect Disabil Res; 2016 Mar; 60(3):282-93. PubMed ID: 26805654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nondeclarative learning in children with specific language impairment: predicting regularities in the visuomotor, phonological, and cognitive domains.
    Mayor-Dubois C; Zesiger P; Van der Linden M; Roulet-Perez E
    Child Neuropsychol; 2014; 20(1):14-22. PubMed ID: 23062060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.
    Descheemaeker MJ; Ghesquière P; Symons H; Fryns JP; Legius E
    J Intellect Disabil Res; 2005 Jan; 49(Pt 1):33-46. PubMed ID: 15634310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental, motor, and language development of toddlers with neurofibromatosis type 1.
    Lorenzo J; Barton B; Acosta MT; North K
    J Pediatr; 2011 Apr; 158(4):660-5. PubMed ID: 21094952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Other impairment associated with developmental language delay in preschool-aged children.
    Chuang YC; Hsu CY; Chiu NC; Lin SP; Tzang RF; Yang CC
    J Child Neurol; 2011 Jun; 26(6):714-7. PubMed ID: 21343604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor function at school age in children with a preschool diagnosis of developmental language impairment.
    Webster RI; Majnemer A; Platt RW; Shevell MI
    J Pediatr; 2005 Jan; 146(1):80-5. PubMed ID: 15644827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive dysfunction in children with neurofibromatosis type 1.
    Rosser TL; Packer RJ
    Curr Neurol Neurosci Rep; 2003 Mar; 3(2):129-36. PubMed ID: 12583841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor proficiency in children with neurofibromatosis type 1.
    Johnson BA; MacWilliams BA; Carey JC; Viskochil DH; D'Astous JL; Stevenson DA
    Pediatr Phys Ther; 2010; 22(4):344-8. PubMed ID: 21068634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.